Celcuity Inc. (CELC) vs Veracyte, Inc. (VCYT)
A side-by-side comparison of Celcuity Inc. and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELC
Celcuity Inc.
$71.57HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
VCYT
Veracyte, Inc.
$44.62HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — CELC vs VCYT
growth of $100 · dividends reinvested · last 9yCELC +415.2% (+20.0%/yr)VCYT +496.6% (+22.0%/yr)VCYT compounded faster over this window
CELC VCYT
CELC vs VCYT: by the numbers
- •VCYT is the larger company ($3.56B vs $3.49B market cap).
- •VCYT is profitable (20.37% net margin) while CELC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CELC | VCYT |
|---|---|---|
| P/E ratio | N/A | 31.87 |
| Forward P/E | N/A | 23.31 |
| P/S ratio | N/A | 6.34 |
| P/B ratio | N/A | 2.56 |
| EV / EBITDA | N/A | 28.32 |
| FCF yield | N/A | 4.65% |
Profitability
| Metric | CELC | VCYT |
|---|---|---|
| Gross margin | 0.00% | 72.09% |
| Operating margin | 0.00% | 17.03% |
| Net margin | 0.00% | 20.37% |
| ROE | N/A | 8.25% |
| ROIC | -28.15% | 6.72% |
Growth (annualized)
| Metric | CELC | VCYT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 28.98% |
| Total return CAGR (5Y) | 34.40% | 1.45% |
Frequently asked
- Is CELC or VCYT more profitable?
- VCYT runs the higher net margin — CELC at 0.00% versus VCYT at 20.37%.
- How have CELC and VCYT total returns compared?
- Over the past 5 years, CELC delivered 34.40% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Veracyte P/E ratioCelcuity ROEVeracyte ROECelcuity operating marginVeracyte operating marginCelcuity revenue growthVeracyte revenue growthCelcuity free cash flowVeracyte free cash flow
Celcuity & Veracyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.